PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
33488293-4	2020	Interestingly, MG-132, a proteasome inhibitor reducing the degradation of MCPIP-1, further facilitated neutrophils to express MCPIP-1 in vitro.	benzyloxycarbonylleucyl-leucyl-leucine aldehyde	15-21	zinc finger CCCH-type containing 12A	Homo sapiens	74-81	
33488293-4	2020	Interestingly, MG-132, a proteasome inhibitor reducing the degradation of MCPIP-1, further facilitated neutrophils to express MCPIP-1 in vitro.	benzyloxycarbonylleucyl-leucyl-leucine aldehyde	15-21	zinc finger CCCH-type containing 12A	Homo sapiens	126-133	
33488293-5	2020	Importantly, MCPIP-1 markedly downregulated the production of ROS, MPO, and proinflammatory cytokines (e.g., interleukin-1beta, interleukin-6, tumor necrosis factor-alpha, interleukin-8, and interferon-gamma) and suppressed the migration of IBD neutrophils.	ros	62-65	zinc finger CCCH-type containing 12A	Homo sapiens	13-20	
33488293-6	2020	Consistently, the same functional changes were observed in neutrophils from mice with myeloid-targeted overexpression of MCPIP-1 as MG-132 did.	benzyloxycarbonylleucyl-leucyl-leucine aldehyde	132-138	zinc finger CCCH type containing 12A	Mus musculus	121-128	
33488293-7	2020	Altogether, these findings suggest that MCPIP-1 plays a negative role in regulating neutrophil activities through suppressing the production of ROS, MPO, and proinflammatory cytokines and inhibiting the migration.	ros	144-147	zinc finger CCCH type containing 12A	Mus musculus	40-47	
33488293-8	2020	MG-132 may partially modulate the function of neutrophils via the induction of MCPIP-1.	benzyloxycarbonylleucyl-leucyl-leucine aldehyde	0-6	zinc finger CCCH type containing 12A	Mus musculus	79-86